BPS warns more clinical pharmacologists needed to improve health of patients and save money

The British Pharmacological Society has launched a report calling for an increase in the number of clinical pharmacologists across the United Kingdom. Clinical Pharmacology is the only specialty that focuses on the safe, effective and economic use of medicines. The discipline is well placed to help the NHS to overcome major current and expected clinical and economic challenges.

The key messages in this report about the importance of Clinical Pharmacology for patient health and cost-effective medicine are also very relevant to patients, health professionals and health systems across the European Union and around the world.

Read more about the report

Read the report

See media coverage of the report

Update on the 12th European Association for Clinical Pharmacology and Therapeutics Congress in Madrid: 27-30 June, 2015

Madrid is the hosting city for the 12th Congress of the European

Habsburg period Plaza Mayor, Madrid

Association for Clinical Pharmacology and Therapeutics, to be held June 27-30, 2015
at the Hotel Meliá Castilla, in the heart of Madrid.
EACPT Congresses attract a worldwide audience. It is the first time the EACPT Congress will take place in Spain.

Our EACPT Congress in Madrid 2015 is being organised in close collaboration between the EACPT and the Spanish Society of Clinical Pharmacology (SEFC).
A key aim of the Congress is to continue the work of the EACPT to strengthen the impact of our discipline across Europe and to make the EACPT both the common home of European Clinical Pharmacologists and a worldwide reference point for professionals in the field. 
This Congress will include contributions from our Portuguese and Latin American colleagues to give this meeting a special intercontinental flavour. 


View the outline scientific program

Abstract submission now open - deadline 3 February 2015

Registration opens soon - Early registration deadline 31 March 2015

SEE YOU ALL IN MADRID!

The official journal of the EACPT is Clinical Therapeutics 

 

Drugs to Fight Cardiovascular Damage: 2014 EACPT Focus Meeting: July 3-5, 2014 in Nijmegen, the Netherlands

The 2014 EACPT Focus Meeting was on the theme of 'Drugs to Fight Cardiovascular Damage'. This 2014 EACPT Focus Meeting took place from July 3rd - 5th at the Radboud University Medical Center in Nijmegen in the Netherlands.

The 2014 EACPT Focus Meeting

• continued excellent tradition of EACPT in providing outstanding meetings for young and senior clinicians and researchers
• provided delegates with the opportunity to attend state of the art lectures from leading professionals and researchers, including hands-on workshops. 
• provided great opportunities for networking with your peers and senior members of the international clinical pharmacology community
• gave easy access for delegates to senior researchers on the international speaker faculty 
• gave the opportunity to have first hand news on major developments for EACPT
• allowed delegates to meet Dr Richard Shader, the editor of the EACPT's Official Journal - Clinical Therapeutics 
• provided delegates with an expert session from Dr Shader on how to publish

In addition to state-of-the-art lectures from international cardiovascular experts, over 60 delegate abstracts were presented  from around the world, with the top 5 ranked abstract presenters  provided with free registration. All abstracts presented at the meeting were published in Clinical Therapeutics, the peer-reviewed Official Journal of the EACPT. 

Selected publications based on the lectures at the Focus Meeting will be published in Clinical Therapeutics. 

This focus meeting follows on from the highly rated  EACPT international summer school in 2013 in Edinburgh.

Radboud University Medical Centre, Nijmegen 

Topics included ultrasound imaging of vascular injury (including a hands-on workshop), the microbiome and inflammation in the metabolic syndrome, targeting inflammation to prevent and treat atherosclerosis, diagnosis and therapy of adrenal hypertension, and protection against ischaemia-reperfusion injury.

This EACPT Cardiovascular Focus Meeting was attended by clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. 

You can listen here to podcasts with international delegates at the last EACPT summer meeting in Edinburgh in 2013.


Visit the Clinical Therapeutics website.

Update from Croatia on the 2015 EACPT Madrid Congress

The Executive Committee of the European Association for Clinical Pharmacology and

Rijeka, Croatia

Therapeutics (EACPT) is meeting from 26-28 September in Rijeka in Croatia, hosted by the Croatian Society for Clinical Pharmacology and Therapeutics    
The main business of this EC meeting includes planning for:
-  the 12th biennial EACPT congress to be held from

Rijeka port

27-29 June 2015 in Madrid
-  further interaction with the official EACPT journal Clinical Therapeutics (online access is a benefit for individual associates of the EACPT)  
-  the next EACPT focus meeting, following the successful EACPT Cardiovascular Focus Meeting held in Nijmegen in the Netherlands, 3-5 July 2014 (selected papers will be published shortly in the offical EACPT journal - Clinical Therapeutics
- interaction with key policy organisations interested in medicines and patient safety, including the European Medicines Agency. EACPT chair Professor Gonzalo Calvo is inaugural co-chair of the Healthcare Professionals Working Party of the European Medicines Agency.

EACPT biennial congresses provide excellent opportunities to showcase issues of topics of  concern to the internationalclinical pharmacology and therapeutics community, through timely and accessible original research presentations and commentaries to policy-makers, health and industry professionals, health technology providers, patient groups and academia.

The Madrid 2015 Congress will bring together a wide range of international delegates,

Royal Palace in Madrid

including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs. 
Key themes at the Madrid congress are expected to include:
- medicines and global health, 

- regulation of biosimilar medicinal products, 

- novel insight into drug ADME,  
- new models of public-private partnership in clinical research, 

- risk adapted clinical trial interventions, 

- pharmacoepidemiology and pharmacovigilance, 

- new pharmacological interventions against Alzheimer's disease,  

- research with electronic health care data,
- advice on writing papers from the Editor of Clinical Therapeutics

- heterogeneity in drug response, 

- the patient's voice in drug selection decisions,  

- translational medicine and pharmacogenetics,  

- therapeutics of wide range of common and serious diseases
- impact of immunosuppression on cancer risk,

- health policy and safe prescribing. 

Sessions will also include discussion about and opportunities for networking in relation to new EACPT-facilitated research networks.

See website for the 12th EACPT Congress to be held in Madrid from 27-29 June 2015.

Register for final places for excellent EACPT summer cardiovascular focus meeting 3-5 July in Holland

You are still in time to register for 2014 EACPT Focus Meeting on 'Drugs to Fight Cardiovascular Damage' from organised by the the European Association for Clinical Pharmacology and Therapeutics [EACPT] .

Registration  - with a preferential accommodation rate - is available through the Focus Meeting website.

The 2014 EACPT Focus Meeting takes place from July 3rd - 5th at the Radboud University Medical Center in Nijmegen in the Netherlands.

Reasons to come to this outstanding meeting

• excellent tradition of EACPT in providing outstanding meetings for young and senior clinicians and researchers
• great opportunities for networking with your peers and senior members of the international clinical pharmacology community
• easy access to senior researchers on the international speaker faculty 
• opportunity to have first hand news on major developments for EACPT
• meet Dr Richard Shader, the editor of the EACPT's Official Journal - Clinical Therapeutics 
• expert session from Dr Shader on how to publish

In addition to state-of-the-art lectures from international cardiovascular experts, over 60 delegate abstracts are due be presented  from around the world. The top 5 ranked abstracts will be provided with free registration. All abstracts presented at the meeting will be published in Clinical Therapeutics, the peer-reviewed Official Journal of the EACPT. 

This focus meeting follows on from the highly rated  EACPT international summer school in 2013 in Edinburgh.

The 2014 EACPT Focus Meeting will provide you with the opportunity to attend state of the art lectures from leading professionals and researchers, including hands-on workshops. 

Radboud University Medical Centre, Nijmegen 

Topics include ultrasound imaging of vascular injury (including a hands-on workshop), the microbiome and inflammation in the metabolic syndrome, targeting inflammation to prevent and treat atherosclerosis, diagnosis and therapy of adrenal hypertension, and protection against ischaemia-reperfusion injury.

This EACPT Cardiovascular Focus Meeting is of interest to clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. 

You can listen here to podcasts with international delegates at the last EACPT summer meeting in Edinburgh in 2013.

See the Scientific Programme is now online on the Focus Meeting website. 

Visit the Clinical Therapeutics website.

Drug Discovery of the Year 2015 opens for nominations

21 May 2014, London UK: The British Pharmacological Society is now accepting nominations from anyone in the world for its third Drug Discovery of the Year award.

The award was established by the Society in 2012 to demonstrate the importance of pharmacology in the development of new medicines, and to reward the achievements of the teams of scientists who discover and develop these drugs.

Previous winners

Drug Discovery of the Year 2013: the Genentech team who developed vismodegib

Drug Discovery of the Year 2014: the GlaxoSmithKline team responsible for trametinib

Professor Humphrey Rang, BPS President, comments: “The British Pharmacological Society was encouraged by the exceptional quality of the nominations received last year. I am delighted to announce the call for submissions to our third Drug Discovery of the Year award and to welcome nominations from across all disease areas that demonstrate the importance of both pre-clinical and clinical pharmacology in translating early discoveries into medicines that benefit patients.”

The Society’s Industry Committee will consider nominations for the discovery team behind a drug – whether a large or a small molecule – that best fulfils the following criteria:

·         preclinical to clinical translation shows the importance of both preclinical and clinical pharmacology in the drug discovery/development process

·         gained regulatory approval within the last three years in the EU and/or US

·         has a significant impact on an unmet medical need

·         first-in-class, or is a significant improvement over other drugs in the class

·         mechanism of action known

Nominations must be received by 1 October 2014. The winning team will be publicly announced during the Society’s flagship meeting Pharmacology 2014, held in London on 16-18 December 2014, and attended by an anticipated 1,000 pharmacologists.

The award does not promote the administration, consumption, prescription, purchase, recommendation, sale, supply or use of the winning medicine; nor does it pre-empt any regulatory decisions. Further information is available from www.bps.ac.uk

Update on July 3-5 EACPT Cardiovascular Focus Meeting in the Netherlands

Following the well-attended EACPT international summer school in 2013 in Edinburgh, the next European Association for Clinical Pharmacology and Therapeutics [EACPT] update for young researchers is the 2014 EACPT Focus Meeting on 'Drugs to Fight Cardiovascular Damage'. The EACPT Focus Meeting will provide you with the opportunity to attend state of the art lectures from leading professionals and researchers, including hands-on workshops. 
Topics include ultrasound imaging of vascular injury (including a hands-on workshop), the microbiome and inflammation in the metabolic syndrome, targeting inflammation to prevent and treat atherosclerosis, diagnosis and therapy of adrenal hypertension, and protection against ischaemia-reperfusion injury.

This EACPT Cardiovascular Focus Meeting is of interest to clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. You can listen here to podcasts with international delegates at the last EACPT summer meeting in Edinburgh in 2013.

The abstract deadline is April 15th - the top 5 ranked abstracts will be provided with free registration. Abstract submission is online on the Focus Meeting website. There are opportunities for both oral and poster presentations within the overall scientific program.  All abstracts presented at the meeting will be published in Clinical Therapeutics, the peer-reviewed Official Journal of the EACPT. 

Registration is now open - with preferential rates if you register by May 15th. A preferential accommodation rate is available through the Focus Meeting website.

The Scientific Programme is now online on the Focus Meeting website. The 2014 EACPT Focus Meeting takes place from July 3rd - 5th at the Radboud University Medical 

Radboud University Medical Centre, Nijmegen

Center in Nijmegen in the Netherlands. 
Visit the Clinical Therapeutics website.

Save the dates for the 12th EACPT Congress in Madrid - 27-30 June, 2015

Madrid will be the hosting city for the 12th Congress of the European

Habsburg period Plaza Mayor, Madrid

Association for Clinical Pharmacology and Therapeutics. It is the first time the EACPT Congress will take place in Spain, following previous presentations of bids for Barcelona 2009 and Valencia 2013.  Although it took some time for the EACPT to accommodate Spain’s enthusiasm to receive the European and Worldwide CPT community, we are delighted that this will finally be a reality in 2015.

EACPT and SEFC will give you the best of themselves to make of this a memorable EACPT conference. Keeping the essence of EACPT meetings, we will aim to make an innovative and attractive program for you all in general, and for young clinical pharmacologists in particular.

EACPT Congresses already attract a worldwide audience. We aim to have relevant contributions from our Portuguese and Latin American colleagues to give this meeting a special intercontinental flavour.

Save the date! The EACPT 12th Congress will take place on 27-30 June 2015, at the Hotel Meliá Castilla, in the heart of Madrid.

The complete scientific program will be released during May this year. The meeting website will be available during March. It will include all important information on the congress, including meeting timelines, registration and accommodation.

SEE YOU ALL IN MADRID!

The official journal of the EACPT is Clinical Therapeutics 

 

Register interest in the EACPT

The EACPT is planning to launch Individual EACPT Associates as a new opportunity to become part of the EACPT and to support its activities. Benefits for Individual EACPT Associates will include

• online access to our official journal – Clinical Therapeutics
• 50% reduction in page charges for publishing in the journal
• involvement in EACPT working groups and other EACPT activities
• opportunities to become involved in partner activities between the EACPT and other organisations

The Individual EACPT Associates initiative will be launched in the Spring of 2014.

2014 EACPT Focus Meeting: 'Drugs to Fight Cardiovascular Damage' 3-5 July, 2014

Following the well-attended EACPT international summer school in 2013 in Edinburgh, the next European Association for Clinical Pharmacology and Therapeutics [EACPT] update for young researchers is the 2014 EACPT Focus Meeting on  'Drugs to Fight Cardiovascular Damage'.

The 2014 EACPT Focus Meeting takes place from July 3rd - 5th at the Radboud University Medical

Radboud University Medical Centre, Nijmegen

Center in Nijmegen in the Netherlands. 

This EACPT cardiovascular focus meeting is of interest to clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. 

Topics include: 
- ultrasound imaging of vascular injury (including a workshop tproviding t hands-on training),
- the microbiome and inflammation in the metabolic syndrome
- targeting inflammation to prevent and treat atherosclerosis
- diagnosis and therapy of adrenal hypertension
- protection against ischaemia-reperfusion injury. 

Provisional State of the Art Lectures by invited speakers include:

Arterial stiffness measurements; methods and relevance for risk assessment and drug-research: Stephane Laurent, Paris, France

IMT measurement with ultrasound, methods and relevance for risk assessment and drug research: Luc van Bortel, Gent, Belgium

The microbiome in the pathogenesis of metabolic syndrome: Max Nieuwdorp

Fat cells and inflammation in the pathogenesis of the Metabolic Syndrome: Rinke Stienstra, Nijmegen, The Netherlands

Predicting and manipulating drug inactivation by the human gut microbiome: H. Haiser. FAS Center for Systems Biology, Harvard University, USA

Cardiac protection by conditioning: from bench to bedside: D. Hausenloy, Hatter Institute, London

The role of hexokinase in cardioprotection: C. Zuurbier, Amsterdam, The Netherlands

Wnt pathways in cardiac repair and remodeling: M. Blankesteijn

Targeting the adaptive immune system in atherosclerosis: Esther Lutgens, AMC, Amsterdam

Trained immunity in the pathogenesis of atherosclerosis: Niels Riksen, Nijmegen, The Netherlands

The pathogenesis of autonomous adrenal aldosterone release: Felix Beuschlein

Diagnosis and treatment of hyperaldosteronism: Jaap Deinum, Nijmegen, The Netherlands

Health professional scientists, academics and  professionals from the pharmaceutical, biotechnology, and related sectors are invited to submit their latest scientific results for oral or poster presentation.

For more information, email  eacpt2014@kenes.com.

Abstract submission and registration will open shortly on our dedicated website.

Abstracts will be published online in Clinical Therapeutics, the Official Journal of the EACPT.